Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: A phase 2 study

Preetesh Jain, Hagop Kantarjian, Elias Jabbour, Graciela Nogueras Gonzalez, Gautam Borthakur, Naveen Pemmaraju, Naval Daver, Evguenia Gachimova, Alessandra Ferrajoli, Steven Kornblau, Farhad Ravandi, Susan O'Brien, Jorge Cortes

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: A phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences